Your browser doesn't support javascript.
loading
Off-target effects of base editors: what we know and how we can reduce it.
Slesarenko, Yana S; Lavrov, Alexander V; Smirnikhina, Svetlana A.
Afiliação
  • Slesarenko YS; Research Centre for Medical Genetics, 1, Moskvorechye str., Moscow, 115522, Russian Federation. yaslesarenkobio@gmail.com.
  • Lavrov AV; Research Centre for Medical Genetics, 1, Moskvorechye str., Moscow, 115522, Russian Federation.
  • Smirnikhina SA; Research Centre for Medical Genetics, 1, Moskvorechye str., Moscow, 115522, Russian Federation.
Curr Genet ; 68(1): 39-48, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34515826
The recently discovered CRISPR-Cas9 modification, base editors (BEs), is considered as one of the most promising tools for correcting disease-causing mutations in humans, since it allows point substitutions to be edited without generating double-stranded DNA breaks, and, therefore, with a significant decrease in non-specific activity. Until recently, this method was considered the safest, but at the same time, it is quite effective. However, recent studies of non-specific activity of BEs revealed that some of them lead to the formation of a huge number of off-targets in both DNA and RNA, occurring due to the nature of the Cas9-fused proteins used. In this review article, we have considered and combined data from numerous studies about the most commonly used and more described in detail APOBEC-based BEs and Target-AID version of CBE, as well as ABE7 and ABE8 with their basic modifications into TadA to improve BEs' specificity. In our opinion, modern advances in molecular genetics make it possible to dramatically reduce the off-target activity of base editors due to introducing mutations into the domains of deaminases or inhibition of Cas9 by anti-CRISPR proteins, which returns BEs to the leading position in genome editing technologies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citosina / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citosina / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2022 Tipo de documento: Article